Showing results (2661-2670 of 3,429) with videos related to
Sort By:
Pageof 343
Eclinicalmedicine|October 31, 2022
Distressing dreams, cognitive decline, and risk of dementia: A prospective study of three population-based cohortsAbidemi I OtaikuEclinicalmedicine|October 7, 2022
Lymphomas associated with Epstein-Barr virus infection in 2020: Results from a large, unselected case series in FranceMarie Donzel, Maxime Bonjour, Jean-Damien Combes, et al.Eclinicalmedicine|October 26, 2022
Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trialJames H McMahon, Jillian S Y Lau, Anna Coldham, et al.Eclinicalmedicine|October 3, 2022
Lung-function trajectories in COVID-19 survivors after discharge: A two-year longitudinal cohort studyHui Zhang, Xia Li, Lixue Huang, et al.Eclinicalmedicine|October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility studyChristopher M Jones, Heather O'Connor, Maria O'Donovan, et al.Eclinicalmedicine|October 4, 2022
The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysisYip Han Chin, Cheng Han Ng, Nicholas Ws Chew, et al.Eclinicalmedicine|March 8, 2021
Epidemiology and clinical features of COVID-19 outbreaks in aged care facilities: A systematic review and meta-analysisMohammad Rashidul Hashan, Nicolas Smoll, Catherine King, et al.Eclinicalmedicine|March 8, 2021
Hydroxychloroquine with or without azithromycin for treatment of early SARS-CoV-2 infection among high-risk outpatient adults: A randomized clinical trialChristine Johnston, Elizabeth R Brown, Jenell Stewart, et al.Eclinicalmedicine|March 8, 2021
Exposome changes in primary school children following the wide population non-pharmacological interventions implemented due to COVID-19 in Cyprus: A national surveyCorina Konstantinou, Xanthi D Andrianou, Andria Constantinou, et al.Eclinicalmedicine|March 8, 2021
Intramuscular midazolam, olanzapine, or haloperidol for the management of acute agitation: A multi-centre, double-blind, randomised clinical trialEsther W Chan, Kim S J Lao, Lam Lam, et al.Pageof 343